Chinese vaccine firm hit with probes as Beijing seeks to tamp down outrage
By Adam Jourdan SHANGHAI (Reuters) – Changsheng Bio-technology Co Ltd, the Chinese vaccine...
Read More
Updated
Eli Lilly to take animal health unit public
(Reuters) – Eli Lilly and Co <LLY.N> said on Tuesday it would spin off its Elanco...
Read MorePepperidge Farm voluntarily recalls Goldfish Crackers on salmonella risk
By Uday Sampath Kumar and Anirban Paul (Reuters) – Pepperidge Farm, owned by Campbell Soup, is voluntarily recalling 3.3 million units of its Goldfish Crackers due to the possible presence of salmonella, the company said...
Read MoreApollo to buy LifePoint in latest private equity bet on healthcare
By Tamara Mathias (Reuters) – Apollo Global Management will buy LifePoint Health in a $5.6 billion deal that will expand its rural U.S. hospitals business, the latest in a series of bets by private equity firms on...
Read More
U.S. FDA staff raises efficacy doubts on GSK’s lung disease treatment
(Reuters) – U.S. Food and Drug Administration staff reviewers have raised doubts over the...
Read More
Bayer to phase out Essure birth control device in U.S.
By Tina Bellon NEW YORK (Reuters) – Life sciences company Bayer AG said on Friday it would...
Read More‘Invisible’ stool blood tied to increased risk of premature death
By Lisa Rapaport (Reuters Health) – A screening test for colon cancer that looks for “invisible” blood in stool may also predict a heightened risk of premature death from other causes, a recent study suggests....
Read More
U.S. court rejects Allergan bid to shield patents through tribe deal
By Jan Wolfe (Reuters) – A U.S. appeals court on Friday rejected a novel strategy adopted by...
Read More
Swiss, German drugmakers join U.S. price freeze
By John Miller ZURICH (Reuters) – European drugmakers Roche, Bayer and Merck KGaA became the...
Read MoreAgios Pharmaceuticals leukemia drug gets U.S. approval
By Tamara Mathias (Reuters) – Agios Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration approved its treatment for a type of leukemia, the first targeted drug for patients with a specific genetic...
Read More
Merck lowers prices of some drugs after Trump calls out industry
By Yasmeen Abutaleb (Reuters) – Merck & Co on Thursday announced price cuts to some of...
Read More
Allergan, Molecular Partners eye drug meets main goal in two studies
(Reuters) – Allergan Plc and Molecular Partners AG said on Thursday their treatment for...
Read MoreMersana’s cancer drug trial put on hold by FDA; shares halted
(Reuters) – Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on partial hold by the U.S. Food and Drug Administration after a patient’s death was possibly linked to...
Read More
Roche takes Tecentriq hit on survival data
By John Miller ZURICH (Reuters) – Roche’s hopes of clinching more of the lung cancer...
Read More
Pharmacy technician charged in case tied to U.S. meningitis outbreak
By Nate Raymond BOSTON (Reuters) – Federal prosecutors on Wednesday charged a pharmacy...
Read More
Lebanon to consider legalizing cannabis growing: official
BEIRUT (Reuters) – Lebanon’s parliament is considering legalizing the cultivation of...
Read More
Abbott Labs raises 2018 earnings forecast, shares hit record high
By Tamara Mathias (Reuters) – Abbott Laboratories raised its full-year earnings forecast and...
Read More
Pfizer-Lilly pain drug meets late-stage trial goals
By Manas Mishra (Reuters) – An experimental osteoarthritis drug developed by Pfizer Inc and...
Read More
Hikma raising injectable opioids output to help ease shortage at U.S. hospitals
LONDON (Reuters) – London-listed pharmaceutical group Hikma <HIK.L> said on Wednesday...
Read More
Cancer drug movie strikes nerve in China, becomes box-office hit
By Christian Shepherd and Pei Li BEIJING (Reuters) – A low-budget Chinese movie about a...
Read More